WCN 2026
28 - 31 March 2026
Effect of once-weekly semaglutide 1.0 mg on kidney outcomes by baseline characteristics: Exploratory data from the FLOW trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.